Global Cancer Incidence and Mortality Rates and Trends—An Update
Tóm tắt
There are limited published data on recent cancer incidence and mortality trends worldwide. We used the International Agency for Research on Cancer's CANCERMondial clearinghouse to present age-standardized cancer incidence and death rates for 2003–2007. We also present trends in incidence through 2007 and mortality through 2012 for select countries from five continents. High-income countries (HIC) continue to have the highest incidence rates for all sites, as well as for lung, colorectal, breast, and prostate cancer, although some low- and middle-income countries (LMIC) now count among those with the highest rates. Mortality rates from these cancers are declining in many HICs while they are increasing in LMICs. LMICs have the highest rates of stomach, liver, esophageal, and cervical cancer. Although rates remain high in HICs, they are plateauing or decreasing for the most common cancers due to decreases in known risk factors, screening and early detection, and improved treatment (mortality only). In contrast, rates in several LMICs are increasing for these cancers due to increases in smoking, excess body weight, and physical inactivity. LMICs also have a disproportionate burden of infection-related cancers. Applied cancer control measures are needed to reduce rates in HICs and arrest the growing burden in LMICs.Cancer Epidemiol Biomarkers Prev; 25(1); 16–27. ©2015 AACR.
See related commentary by Bray, p. 3
Từ khóa
Tài liệu tham khảo
International Agency for Research on Cancer Section of Cancer Surveillance
Bray, 2015, Cancer Incidence in Five Continents: inclusion criteria, highlights from Volume X and the global status of cancer registration, Int J Cancer, 137, 2060, 10.1002/ijc.29670
Surveillance, Epidemiology, and End Results Program
Engholm, NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 7.1 (09.07.2015)
Ferlay, GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]
Doll, 1967, Summarizing indices for comparison of cancer incidence data, Int J Cancer, 2, 269, 10.1002/ijc.2910020310
Jemal, 2008, Annual report to the nation on the status of cancer, 1975–2005, featuring trends in lung cancer, tobacco use, and tobacco control, J Natl Cancer Inst, 100, 1672, 10.1093/jnci/djn389
Thun, 2012, Stages of the cigarette epidemic on entering its second century, Tob Control, 21, 96, 10.1136/tobaccocontrol-2011-050294
Torre, 2014, International variation in lung cancer mortality rates and trends among women, Cancer Epidemiol Biomarkers Prev, 23, 1025, 10.1158/1055-9965.EPI-13-1220
World Health Organization, WHO Framework Convention on Tobacco Control Overview
Aberle, 2011, Reduced lung-cancer mortality with low-dose computed tomographic screening, New Engl J Med, 365, 395, 10.1056/NEJMoa1102873
Loomis, 2013, The carcinogenicity of outdoor air pollution, Lancet Oncol, 14, 1262, 10.1016/S1470-2045(13)70487-X
2012
Mu, 2013, Indoor air pollution and risk of lung cancer among Chinese female non-smokers, Cancer Causes Control, 24, 439, 10.1007/s10552-012-0130-8
Zhang, 2012, Trends in mortality from cancers of the breast, colon, prostate, esophagus, and stomach in East Asia: role of nutrition transition, Eur J Cancer Prev, 21, 480, 10.1097/CEJ.0b013e328351c732
Chatenoud, 2014, Trends in mortality from major cancers in the Americas: 1980–2010, Ann Oncol, 25, 1843, 10.1093/annonc/mdu206
Arnold, 2015, Recent trends in incidence of five common cancers in 26 European countries since 1988: analysis of the European Cancer Observatory, Eur J Cancer, 51, 1164, 10.1016/j.ejca.2013.09.002
Edwards, 2010, Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates, Cancer, 116, 544, 10.1002/cncr.24760
Bosetti, 2013, Cancer mortality in Europe, 2005–2009, and an overview of trends since 1980, Ann Oncol, 24, 2657, 10.1093/annonc/mdt301
Young, 2015, Rising incidence of early-onset colorectal cancer in Australia over two decades: report and review, J Gastroenterol Hepatol, 30, 6, 10.1111/jgh.12792
Bosetti, 2011, Recent trends in colorectal cancer mortality in Europe, Int J Cancer, 129, 180, 10.1002/ijc.25653
Ouyang, 2005, Noninvasive testing for colorectal cancer: a review, Am J Gastroenterol, 100, 1393, 10.1111/j.1572-0241.2005.41427.x
Redwood, 2014, Comparison of fecal occult blood tests for colorectal cancer screening in an Alaska Native population with high prevalence of Helicobacter pylori infection, 2008–2012, Prev Chronic Dis, 11, E56, 10.5888/pcd11.130281
Imperiale, 2014, Multitarget stool DNA testing for colorectal-cancer screening, New Engl J Med, 370, 1287, 10.1056/NEJMoa1311194
U.S. Food and Drug Administration, 2014, FDA approves first non-invasive DNA screening test for colorectal cancer
Jemal, 2014, The Cancer Atlas, 2nd edition
Lambert, 2009, Mass screening for colorectal cancer is not justified in most developing countries, Int J Cancer, 125, 253, 10.1002/ijc.24371
Althuis, 2005, Global trends in breast cancer incidence and mortality 1973–1997, Int J Epidemiol, 34, 405, 10.1093/ije/dyh414
Chlebowski, 2013, Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study, J Natl Cancer Inst, 105, 526, 10.1093/jnci/djt043
Colditz, 2006, Breast cancer, 3rd ed, 995
Youlden, 2012, The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality, Cancer Epidemiol, 36, 237, 10.1016/j.canep.2012.02.007
Colditz, 2006, Epidemiology - identifying the causes and preventability of cancer?, Nat Rev Cancer, 6, 75, 10.1038/nrc1784
Autier, 2011, Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database, BMJ, 343, d4411, 10.1136/bmj.d4411
Berry, 2005, Effect of screening and adjuvant therapy on mortality from breast cancer, New Engl J Med, 353, 1784, 10.1056/NEJMoa050518
Bosetti, 2012, The decline in breast cancer mortality in Europe: an update (to 2009), Breast, 21, 77, 10.1016/j.breast.2011.08.001
Bray, 2012, Global cancer transitions according to the Human Development Index (2008–2030): a population-based study, Lancet Oncol, 13, 790, 10.1016/S1470-2045(12)70211-5
Youlden, 2014, Incidence and mortality of female breast cancer in the Asia-Pacific region, Cancer Biol Med, 11, 101
Smith, 2014, The value of modern mammography screening in the control of breast cancer: understanding the underpinnings of the current debates, Cancer Epidemiol Biomarkers Prev, 23, 1139, 10.1158/1055-9965.EPI-13-0946
Pace, 2014, A systematic assessment of benefits and risks to guide breast cancer screening decisions, JAMA, 311, 1327, 10.1001/jama.2014.1398
Vainio, 2002, Breast cancer screening
Anderson, 2011, Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010, Lancet Oncol, 12, 387, 10.1016/S1470-2045(11)70031-6
Center, 2012, International variation in prostate cancer incidence and mortality rates, Eur Urol, 61, 1079, 10.1016/j.eururo.2012.02.054
Rebbeck, 2013, Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent, Prostate Cancer, 2013, 560857, 10.1155/2013/560857
Baade, 2009, International epidemiology of prostate cancer: geographical distribution and secular trends, Mol Nutr Food Res, 53, 171, 10.1002/mnfr.200700511
Potosky, 1990, Rise in prostatic cancer incidence associated with increased use of transurethral resection, J Natl Cancer Inst, 82, 1624, 10.1093/jnci/82.20.1624
Andriole, 2012, Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up, J Natl Cancer Inst, 104, 125, 10.1093/jnci/djr500
Schroder, 2012, Prostate-cancer mortality at 11 years of follow-up, New Engl J Med, 366, 981, 10.1056/NEJMoa1113135
Draisma, 2009, Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context, J Natl Cancer Inst, 101, 374, 10.1093/jnci/djp001
Cuzick, 2014, Prevention and early detection of prostate cancer, Lancet Oncol, 15, e484, 10.1016/S1470-2045(14)70211-6
Lacy, 2014, A tale of two trials: the impact of 5alpha-reductase inhibition on prostate cancer (Review), Oncol Lett, 8, 1391, 10.3892/ol.2014.2388
Plummer, 2015, Global burden of gastric cancer attributable to pylori, Int J Cancer, 136, 487, 10.1002/ijc.28999
Karimi, 2014, Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention, Cancer Epidemiol Biomarkers Prev, 23, 700, 10.1158/1055-9965.EPI-13-1057
Parkin, 2006, The global health burden of infection-associated cancers in the year 2002, Int J Cancer, 118, 3030, 10.1002/ijc.21731
Bertuccio, 2009, Recent patterns in gastric cancer: a global overview, Int J Cancer, 125, 666, 10.1002/ijc.24290
Anderson, 2010, Age-specific trends in incidence of noncardia gastric cancer in US adults, JAMA, 303, 1723, 10.1001/jama.2010.496
de Martel, 2013, Gastric cancer: epidemiology and risk factors, Gastroenterol Clin North Am, 42, 219, 10.1016/j.gtc.2013.01.003
Camargo, 2011, Divergent trends for gastric cancer incidence by anatomical subsite in US adults, Gut, 60, 1644, 10.1136/gut.2010.236737
Steevens, 2010, Trends in incidence of oesophageal and stomach cancer subtypes in Europe, Eur J Gastroenterol Hepatol, 22, 669
Corley, 2004, Influence of site classification on cancer incidence rates: an analysis of gastric cardia carcinomas, J Natl Cancer Inst, 96, 1383, 10.1093/jnci/djh265
Devesa, 1998, Changing patterns in the incidence of esophageal and gastric carcinoma in the United States, Cancer, 83, 2049, 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2
London, 2006, Liver cancer, 3rd ed, 763
Mittal, 2013, Epidemiology of hepatocellular carcinoma: consider the population, J Clin Gastroenterol, 47, S2, 10.1097/MCG.0b013e3182872f29
Shin, 2010, Epidemiology of cholangiocarcinoma: an update focusing on risk factors, Cancer Sci, 101, 579, 10.1111/j.1349-7006.2009.01458.x
Bosetti, 2014, Hepatocellular carcinoma epidemiology, Best Pract Res Clin Gastroenterol, 28, 753, 10.1016/j.bpg.2014.08.007
Altekruse, 2009, Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005, J Clin Oncol, 27, 1485, 10.1200/JCO.2008.20.7753
McGlynn, 2015, Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability, Clin Liver Dis, 19, 223, 10.1016/j.cld.2015.01.001
Tanaka, 2011, Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures, J Epidemiol, 21, 401, 10.2188/jea.JE20100190
Tanaka, 2008, Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003, Ann Intern Med, 148, 820, 10.7326/0003-4819-148-11-200806030-00004
Chiang, 2013, Thirty-year outcomes of the national hepatitis B immunization program in Taiwan, JAMA, 310, 974, 10.1001/jama.2013.276701
Lu, 2013, Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infection, World J Gastroenterol, 19, 8887, 10.3748/wjg.v19.i47.8887
Centers for Disease Control and Prevention, 2014, CDC recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945–1965
Duangsong, 2013, Development of a community-based approach to opisthorchiasis control, Asian Pac J Cancer Prev, 14, 7039, 10.7314/APJCP.2013.14.11.7039
Sithithaworn, 2014, Roles of liver fluke infection as risk factor for cholangiocarcinoma, J Hepatobiliary Pancreat Sci, 21, 301, 10.1002/jhbp.62
Islami, 2009, High-temperature beverages and foods and esophageal cancer risk—a systematic review, Int J Cancer, 125, 491, 10.1002/ijc.24445
Islami, 2009, Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case–control study, BMJ, 338, b929, 10.1136/bmj.b929
Rasool, 2012, Esophageal cancer: associated factors with special reference to the Kashmir Valley, Tumori, 98, 191, 10.1177/030089161209800203
Wu, 2009, Green tea drinking, high tea temperature and esophageal cancer in high- and low-risk areas of Jiangsu Province, China: a population-based case–control study, Int J Cancer, 124, 1907, 10.1002/ijc.24142
Jemal, 2012, Cancer burden in Africa and opportunities for prevention, Cancer, 118, 4372, 10.1002/cncr.27410
Engel, 2003, Population attributable risks of esophageal and gastric cancers, J Natl Cancer Inst, 95, 1404, 10.1093/jnci/djg047
Kamangar, 2009, Environmental causes of esophageal cancer, Gastroenterol Clin North Am, 38, 27, 10.1016/j.gtc.2009.01.004
Castro, 2014, Patterns and trends in esophageal cancer mortality and incidence in Europe (1980–2011) and predictions to 2015, Ann Oncol, 25, 283, 10.1093/annonc/mdt486
Cook, 2009, Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977–2005, Br J Cancer, 101, 855, 10.1038/sj.bjc.6605246
Otterstatter, 2012, Esophageal cancer in Canada: trends according to morphology and anatomical location, Can J Gastroenterol, 26, 723, 10.1155/2012/649108
Islami, 2008, Helicobacter pylori and esophageal cancer risk: a meta-analysis, Cancer Prev Res, 1, 329, 10.1158/1940-6207.CAPR-08-0109
Lagergren, 2013, Recent developments in esophageal adenocarcinoma, CA Cancer J Clin, 63, 232, 10.3322/caac.21185
Xie, 2013, Helicobacter pylori infection and esophageal cancer risk: an updated meta-analysis, World J Gastroenterol, 19, 6098, 10.3748/wjg.v19.i36.6098
Zhang, 2013, Epidemiology of esophageal cancer, World J Gastroenterol, 19, 5598, 10.3748/wjg.v19.i34.5598
Ballester, 2014, Endoscopic surveillance of gastrointestinal premalignant lesions: current knowledge and future directions, Curr Opin Gastroenterol, 30, 477, 10.1097/MOG.0000000000000090
Verbeek, 2014, Surveillance of Barrett's esophagus and mortality from esophageal adenocarcinoma: a population-based cohort study, Am J Gastroenterol, 109, 1215, 10.1038/ajg.2014.156
Bruni, 2010, Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings, J Infect Dis, 202, 1789, 10.1086/657321
Forman, 2012, Global burden of human papillomavirus and related diseases, Vaccine, 30, F12, 10.1016/j.vaccine.2012.07.055
Vaccarella, 2013, Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors, Eur J Cancer, 49, 3262, 10.1016/j.ejca.2013.04.024
De Vuyst, 2013, The burden of human papillomavirus infections and related diseases in sub-saharan Africa, Vaccine, 31, F32, 10.1016/j.vaccine.2012.07.092
Bray, 2005, Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening, Cancer Epidemiol Biomarkers Prev, 14, 677, 10.1158/1055-9965.EPI-04-0569
Gustafsson, 1997, International incidence rates of invasive cervical cancer after introduction of cytological screening, Cancer Causes Control, 8, 755, 10.1023/A:1018435522475
Bray, 2013, Patterns and trends in human papillomavirus-related diseases in Central and Eastern Europe and Central Asia, Vaccine, 31, H32, 10.1016/j.vaccine.2013.02.071
Wabinga, 2000, Trends in cancer incidence in Kyadondo County, Uganda, 1960–1997, Br J Cancer, 82, 1585
Chokunonga, 2013, Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991–2010, Int J Cancer, 133, 721, 10.1002/ijc.28063
Maver, 2013, Cervical cancer screening practices in central and eastern Europe in 2012, Acta Dermatovenerol Alp Pannonica Adriat, 22, 7
Herrero, 2015, Present status of human papillomavirus vaccine development and implementation, Lancet Oncol, 16, e206, 10.1016/S1470-2045(14)70481-4
GAVI, 2013, Millions of girls in developing countries to be protected against cervical cancer thanks to new HPV vaccine deals
Kreimer, 2015, Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials, Lancet Oncol, 16, 775, 10.1016/S1470-2045(15)00047-9
World Health Organization, 2014, Human papillomavirus vaccines: WHO position paper, October 2014, Wkly Epidemiol Rec, 89, 465
Kreimer, 2015, The case for conducting a randomized clinical trial to assess the efficacy of a single dose of prophylactic HPV vaccines among adolescents, J Natl Cancer Inst, 107, 10.1093/jnci/dju436
Wright, 2012, Alternative approaches to cervical cancer screening for developing countries, Best Pract Res Clin Obstet Gynaecol, 26, 197, 10.1016/j.bpobgyn.2011.11.004
International Association of Cancer Registries, CI5 - XI call for data launched
International Agency for Research on Cancer, Global Initiative for Cancer Registry Development
Mathers, 2005, Counting the dead and what they died from: an assessment of the global status of cause of death data, Bull World Health Organ, 83, 171